What: Boston Magazine discusses how overwhelming Instagram ads for menopause treatments burden women during perimenopause.
Key line: [Details not provided].
Source: Boston Magazine.
What: Boston Magazine discusses how overwhelming Instagram ads for menopause treatments burden women during perimenopause.
Key line: [Details not provided].
Source: Boston Magazine.
Mouse study reveals female hormones help trigger opioid production in spinal cord immune cells.
Florida experienced the biggest abortion drop nationwide after its ban took effect.
A state judge loosens the law—but only slightly—on when abortions can be provided.
Oprah opens up about her menopause journey and brings national attention to a long-ignored health topic.
Bladder-leak brand Poise proposes using pads for hormone testing in rural areas.
Year-long birth control prescriptions could cut unintended pregnancies and save money, says R Street.
Florida experienced the biggest abortion drop nationwide after its ban took effect.
Year-long birth control prescriptions could cut unintended pregnancies and save money, says R Street.
Study shows women over 70 who screened regularly were diagnosed earlier and had lower mortality.
Trump promotes IVF access while cutting the team responsible for tracking it.
Maternie’s live tracker outlines federal program cuts, including Title X and IVF teams.
WHI funding restored after backlash; $140 saved for every dollar spent, researchers say.
Maternie’s live tracker outlines federal program cuts, including Title X and IVF teams.
Study finds no added benefit from multi-drug regimens for women with heart pain but no artery blockage.
Science reports the entire CDC team behind contraceptive safety guidelines has been ousted.
Report finds mortality jumped in Texas post-ban; researchers call it a canary in the coal mine.
Even with dye bans, ultra-processed food remains the real issue, The Atlantic argues.
The Economist finds abortions have increased in some states *after* bans, thanks to telehealth and shield laws.
Researchers call for standardized criteria to assess dangerous placenta conditions.
One-third of patients spend more than $50,000 on fertility treatments, according to a new survey.